CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 34.72
+0.84 (2.48%)
Mar 10, 2026, 1:15 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 13.72 billion as of March 9, 2026. Its market cap has increased by 13.49% in one year.
Market Cap
13.72B
Enterprise Value
12.20B
Revenue
1.19B
Ranking
n/a
PE Ratio
276.78
Stock Price
34.72
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 13.72B, an increase of 81.16%. That is a compound annual growth rate of 8.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Consun Pharmaceutical Group | 13.70B |
| CF PharmTech | 14.02B |
| Sihuan Pharmaceutical Holdings Group | 13.35B |
| Luye Pharma Group | 10.11B |
| Shandong Xinhua Pharmaceutical Company | 10.06B |
| China Traditional Chinese Medicine Holdings Co. | 9.87B |
| Ab&B Bio-Tech CO., LTD. JS | 20.71B |
| OneRobotics (Shenzhen) | 23.98B |